PFC Pharma Focus AG And Maccabi Healthcare Services Use Database Resources To Provide Innovative Clinical Research Optimization Services To The Pharmaceutical And Medical Device Industry
6/8/2010 11:00:34 AM
June 8 Zurich, PFC Pharma Focus, an internationally recognized CRO, announces the launch of a new collaboration with Maccabi HealthCare Services, a leading not for profit HMO with almost 2 million subscribers. Together, they will provide integrated clinical research optimization services designed to better meet the needs of the pharmaceutical industry. Maccabi's 15 years of database research experience enable PFC to leverage its 18 years of experience in clinical development to streamline clinical studies. Access to Maccabi's robust, multidimensional clinical database and patient registries will significantly reduce the risks of clinical research and will shorten time to market.
“With the power of Maccabi's rich database resources and cutting edge database research capabilities, PFC can now offer clients enhanced research planning services, including feasibility studies, patient profiling and real time automated patient recruitment tools. Maccabi's database enables drug safety and outcomes studies, epidemiological studies, and pharmaco-economic research”, said Ran Frenkel, RPh, VP Business Development PFC Pharma Focus.
The database includes complete anonymized outpatient records from primary care and specialty physicians, laboratory results, comprehensive drug prescription and purchasing information, centralized digitized images and hospitalization data. Maccabi's patient registries include diabetes, cardiovascular, infertility, hypertension, home care, oncology, psychiatry and anticoagulation treatment. Maccabi's fully integrated electronic medical record permits customized queries to physicians to obtain additional information not routinely collected, while safeguarding patient confidentiality. Based on these cutting edge capabilities, Maccabi's database research team has published extensively in the professional literature, including articles in: Annals of Epidemiology (2010); Archives of Internal Medicine (2009); Annals of Pharmacotherapy (2009); Clinical Therapeutics (2008); Journal of Clinical Epidemiology (2007); Preventative Medicine (2006).
"We are pleased that through this collaboration with Pharma Focus, Maccabi will be able to leverage its unique data resources and research experience to expedite the development of new drugs and treatments for our patients and people everywhere," said Prof Ehud Kokia, MD, CEO of Maccabi HealthCare Services.
Maccabi HealthCare Services
Maccabi Healthcare Services, Israel’s most advanced non-profit health fund, provides comprehensive medical coverage to 1.9 million members (25% of the country's total population). Maccabi has long been recognized, both in Israel and abroad, as a unique and innovative health care system, leading the way in many areas including cutting edge medical technology, comprehensive and integrated computerized information systems, cost–effective management, and sophisticated evaluation tools. For more information about Maccabi go to: www.maccabi4u.co.il
PFC Pharma Focus
Based in Switzerland, PFC Pharma Focus is a premium contract research organization (CRO), providing product development services in the life science and health care industries. Founded in 1992 by prominent experts in all realms of clinical services, the mission of PFC Pharma Focus is to bring a new focus to the drug development experience by addressing the limitations of conventional study practices. This year marks PFC's 18th anniversary providing clinical services to clients and partners, which include pharmaceutical, biotechnology, medical device, and academic and government organizations. PFC services encompass clinical development consultancy, clinical operations and project management, medical writing, regulatory affairs, training in pharmaceutical medicine and development of risk management plans. PFC also has operations in Germany, India and Israel.
For more information about PFC Pharma Focus go to: www.pfc-cro.com
comments powered by